Global Motion Sickness Treatment Market by Route of Administration (Oral, Transdermal), by End User (Retail Pharmacies, Hospitals, Online Pharmacies), by Treatment Type (Antihistamines, Anticholinergic) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Motion Sickness Treatment Market research report which is segmented by Route of Administration (Oral, Transdermal), by End User (Retail Pharmacies, Hospitals, Online Pharmacies), by Treatment Type (Antihistamines, Anticholinergic), By Players/Companies Caleb Pharmaceuticals Inc., CVS Health, GlaxoSmithKline Plc., Reliefband Technologies LLC., WellSpring Pharmaceutical Corporation, Myungmoon Pharm Co. Ltd., Baxter International Inc., Prestige Brands Inc., Pfizer, Perrigo Company Plc.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Motion Sickness Treatment Market Research Report |
By Route of Administration | Oral, Transdermal |
By End User | Retail Pharmacies, Hospitals, Online Pharmacies |
By Treatment Type | Antihistamines, Anticholinergic |
By Companies | Caleb Pharmaceuticals Inc., CVS Health, GlaxoSmithKline Plc., Reliefband Technologies LLC., WellSpring Pharmaceutical Corporation, Myungmoon Pharm Co. Ltd., Baxter International Inc., Prestige Brands Inc., Pfizer, Perrigo Company Plc. |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 210 |
Number of Tables & Figures | 147 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Motion Sickness Treatment Market Report Segments:
The market is segmented by Route of Administration (Oral, Transdermal), by End User (Retail Pharmacies, Hospitals, Online Pharmacies), by Treatment Type (Antihistamines, Anticholinergic).
Some of the companies that are profiled in this report are:
- Caleb Pharmaceuticals Inc.
- CVS Health
- GlaxoSmithKline Plc.
- Reliefband Technologies LLC.
- WellSpring Pharmaceutical Corporation
- Myungmoon Pharm Co. Ltd.
- Baxter International Inc.
- Prestige Brands Inc.
- Pfizer
- Perrigo Company Plc.
Motion Sickness Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Motion Sickness Treatment Market
Overview of the regional outlook of the Motion Sickness Treatment Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Motion Sickness Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Motion Sickness Treatment Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Oral
2. Transdermal
7. By End User:1. Retail Pharmacies
2. Hospitals
3. Online Pharmacies
8. By Treatment Type:1. Antihistamines
2. Anticholinergic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Motion Sickness Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Motion Sickness Treatment Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Motion Sickness Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Motion Sickness Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Motion Sickness Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Motion Sickness Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Motion Sickness Treatment Market Size & Forecast, 2018-2028
4.5.1 Motion Sickness Treatment Market Size and Y-o-Y Growth
4.5.2 Motion Sickness Treatment Market Absolute $ Opportunity
Chapter 5 Global Motion Sickness Treatment Market Analysis and Forecast by Route of Administration
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Route of Administration
5.1.2 Basis Point Share (BPS) Analysis by Route of Administration
5.1.3 Absolute $ Opportunity Assessment by Route of Administration
5.2 Motion Sickness Treatment Market Size Forecast by Route of Administration
5.2.1 Oral
5.2.2 Transdermal
5.3 Market Attractiveness Analysis by Route of Administration
Chapter 6 Global Motion Sickness Treatment Market Analysis and Forecast by End User
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End User
6.1.2 Basis Point Share (BPS) Analysis by End User
6.1.3 Absolute $ Opportunity Assessment by End User
6.2 Motion Sickness Treatment Market Size Forecast by End User
6.2.1 Retail Pharmacies
6.2.2 Hospitals
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by End User
Chapter 7 Global Motion Sickness Treatment Market Analysis and Forecast by Treatment Type
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Treatment Type
7.1.2 Basis Point Share (BPS) Analysis by Treatment Type
7.1.3 Absolute $ Opportunity Assessment by Treatment Type
7.2 Motion Sickness Treatment Market Size Forecast by Treatment Type
7.2.1 Antihistamines
7.2.2 Anticholinergic
7.3 Market Attractiveness Analysis by Treatment Type
Chapter 8 Global Motion Sickness Treatment Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Motion Sickness Treatment Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Motion Sickness Treatment Analysis and Forecast
10.1 Introduction
10.2 North America Motion Sickness Treatment Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Motion Sickness Treatment Market Size Forecast by Route of Administration
10.6.1 Oral
10.6.2 Transdermal
10.7 Basis Point Share (BPS) Analysis by Route of Administration
10.8 Absolute $ Opportunity Assessment by Route of Administration
10.9 Market Attractiveness Analysis by Route of Administration
10.10 North America Motion Sickness Treatment Market Size Forecast by End User
10.10.1 Retail Pharmacies
10.10.2 Hospitals
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by End User
10.12 Absolute $ Opportunity Assessment by End User
10.13 Market Attractiveness Analysis by End User
10.14 North America Motion Sickness Treatment Market Size Forecast by Treatment Type
10.14.1 Antihistamines
10.14.2 Anticholinergic
10.15 Basis Point Share (BPS) Analysis by Treatment Type
10.16 Absolute $ Opportunity Assessment by Treatment Type
10.17 Market Attractiveness Analysis by Treatment Type
Chapter 11 Europe Motion Sickness Treatment Analysis and Forecast
11.1 Introduction
11.2 Europe Motion Sickness Treatment Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Motion Sickness Treatment Market Size Forecast by Route of Administration
11.6.1 Oral
11.6.2 Transdermal
11.7 Basis Point Share (BPS) Analysis by Route of Administration
11.8 Absolute $ Opportunity Assessment by Route of Administration
11.9 Market Attractiveness Analysis by Route of Administration
11.10 Europe Motion Sickness Treatment Market Size Forecast by End User
11.10.1 Retail Pharmacies
11.10.2 Hospitals
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by End User
11.12 Absolute $ Opportunity Assessment by End User
11.13 Market Attractiveness Analysis by End User
11.14 Europe Motion Sickness Treatment Market Size Forecast by Treatment Type
11.14.1 Antihistamines
11.14.2 Anticholinergic
11.15 Basis Point Share (BPS) Analysis by Treatment Type
11.16 Absolute $ Opportunity Assessment by Treatment Type
11.17 Market Attractiveness Analysis by Treatment Type
Chapter 12 Asia Pacific Motion Sickness Treatment Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Motion Sickness Treatment Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Motion Sickness Treatment Market Size Forecast by Route of Administration
12.6.1 Oral
12.6.2 Transdermal
12.7 Basis Point Share (BPS) Analysis by Route of Administration
12.8 Absolute $ Opportunity Assessment by Route of Administration
12.9 Market Attractiveness Analysis by Route of Administration
12.10 Asia Pacific Motion Sickness Treatment Market Size Forecast by End User
12.10.1 Retail Pharmacies
12.10.2 Hospitals
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by End User
12.12 Absolute $ Opportunity Assessment by End User
12.13 Market Attractiveness Analysis by End User
12.14 Asia Pacific Motion Sickness Treatment Market Size Forecast by Treatment Type
12.14.1 Antihistamines
12.14.2 Anticholinergic
12.15 Basis Point Share (BPS) Analysis by Treatment Type
12.16 Absolute $ Opportunity Assessment by Treatment Type
12.17 Market Attractiveness Analysis by Treatment Type
Chapter 13 Latin America Motion Sickness Treatment Analysis and Forecast
13.1 Introduction
13.2 Latin America Motion Sickness Treatment Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Motion Sickness Treatment Market Size Forecast by Route of Administration
13.6.1 Oral
13.6.2 Transdermal
13.7 Basis Point Share (BPS) Analysis by Route of Administration
13.8 Absolute $ Opportunity Assessment by Route of Administration
13.9 Market Attractiveness Analysis by Route of Administration
13.10 Latin America Motion Sickness Treatment Market Size Forecast by End User
13.10.1 Retail Pharmacies
13.10.2 Hospitals
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by End User
13.12 Absolute $ Opportunity Assessment by End User
13.13 Market Attractiveness Analysis by End User
13.14 Latin America Motion Sickness Treatment Market Size Forecast by Treatment Type
13.14.1 Antihistamines
13.14.2 Anticholinergic
13.15 Basis Point Share (BPS) Analysis by Treatment Type
13.16 Absolute $ Opportunity Assessment by Treatment Type
13.17 Market Attractiveness Analysis by Treatment Type
Chapter 14 Middle East & Africa (MEA) Motion Sickness Treatment Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Motion Sickness Treatment Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Motion Sickness Treatment Market Size Forecast by Route of Administration
14.6.1 Oral
14.6.2 Transdermal
14.7 Basis Point Share (BPS) Analysis by Route of Administration
14.8 Absolute $ Opportunity Assessment by Route of Administration
14.9 Market Attractiveness Analysis by Route of Administration
14.10 Middle East & Africa (MEA) Motion Sickness Treatment Market Size Forecast by End User
14.10.1 Retail Pharmacies
14.10.2 Hospitals
14.10.3 Online Pharmacies
14.11 Basis Point Share (BPS) Analysis by End User
14.12 Absolute $ Opportunity Assessment by End User
14.13 Market Attractiveness Analysis by End User
14.14 Middle East & Africa (MEA) Motion Sickness Treatment Market Size Forecast by Treatment Type
14.14.1 Antihistamines
14.14.2 Anticholinergic
14.15 Basis Point Share (BPS) Analysis by Treatment Type
14.16 Absolute $ Opportunity Assessment by Treatment Type
14.17 Market Attractiveness Analysis by Treatment Type
Chapter 15 Competition Landscape
15.1 Motion Sickness Treatment Market: Competitive Dashboard
15.2 Global Motion Sickness Treatment Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Caleb Pharmaceuticals Inc.
15.3.2 CVS Health
15.3.3 GlaxoSmithKline Plc.
15.3.4 Reliefband Technologies LLC.
15.3.5 WellSpring Pharmaceutical Corporation
15.3.6 Myungmoon Pharm Co. Ltd.
15.3.7 Baxter International Inc.
15.3.8 Prestige Brands Inc.
15.3.9 Pfizer
15.3.10 Perrigo Company Plc.